Additionally, this study emphasized the connection between pancancer-level IL18RAP expression and clinical prognosis, DNA methylation, tumor mutation burden (TMB), TME, microsatellite instability (MSI), and immunotherapy. Here, IL18RAP is linked to neoplasm.